The former is a well-known apoptosis switch, with a progressive reduction of the Bcl-2/Bax ratio having been reported during the progression of NAFLD to NASH which correlates to the apoptosis percentage of hepatocytes [56]. This evidence concerns the gene BAX and metabolic dysfunction-associated steatohepatitis.